An open-label pilot study of Herceptin monotherapy on objective treatment response in patients with metastatic or locally advanced gastric cancer who had disease progression during platinum-based or 5-fluoropyrimidine-based chemotherapy.

Trial Profile

An open-label pilot study of Herceptin monotherapy on objective treatment response in patients with metastatic or locally advanced gastric cancer who had disease progression during platinum-based or 5-fluoropyrimidine-based chemotherapy.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 22 Aug 2014

At a glance

  • Drugs Trastuzumab (Primary)
  • Indications Gastric cancer
  • Focus Therapeutic Use
  • Sponsors Roche
  • Most Recent Events

    • 09 Aug 2014 Status changed from completed to discontinued as reported by ClincialTrials.gov.
    • 16 Feb 2008 Status changed from in progress to completed.
    • 23 Jan 2008 Status changed from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top